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Abstract. Using the model of isolated perfused rat kidneys 
this study was performed to investigate whether or not 
voltage-operated calcium channels are essentially in- 
volved in the pressure control of renin secretion from the 
kidneys. At a perfusion pressure of 100 mm Hg (13.3 kPa) 
renin secretory rates were 4.2 _+ 0.7 (ng angiotensin I h- 1) 
min-1 g-1. Stepwise reduction of renal perfusion pres- 
sure to 80, 60, and 40 mm Hg (10.6, 8.0, 5.3 kPa) resulted 
in an increase of renin release yielding a 30-fold stimu- 
lation at 40 mm Hg vs 100 mm Hg. Increasing the per- 
fusion pressure above 100 mm Hg did not further signifi- 
cantly decrease renin secretion. The perfusate flow rate 
was also pressure-dependent. Flow rates increased lin- 
early with pressure and reached aplateau at 100 mm Hg, 
which was maintained up to 160 mm Hg (21.3 kPa). The 
averaged flow rate at the plateau was 15.5 ml rain- 1 g- 1. 
In the presence of the three different calcium antagonists 
nifedipine (5 gM), nitrendipine (3 gM) and verapamil 
(5 laM), myogenic autoregulation f flow was abolished 
as indicated by the rise of the pressure/flow curve between 
40 and 160 mm Hg. At the same time, however, these 
calcium channel blockers did not alter the relationship 
between perfusion pressure and renin secretion. More- 
over, the calcium channel agonist Bay K 8644 (5 gM) 
caused a strong and long-lasting vasoconstriction, with- 
out changing renin secretion. Taken together, our 
findings indicate that organic alcium antagonists atcon- 
centrations sufficient to block voltage-operated calcium 
channels in vascular smooth muscle cells have no influ- 
ence on the pressure-dependent co trol ofrenin secretion. 
In consequence, it appears unlikely that voltage-operated 
calcium channels are essentially involved in the signal 
transduction mechanism that links renin secretion and 
blood pressure. 
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Introduction 
Since the original work by Goldblatt [10] it has been well 
established that the blood pressure isan essential control 
factor for the secretion of renin from the kidneys [7, 17, 
20, 34, 38]. Within the kidneys renin is released from the 
juxtaglomerular epitheloid (JG) cells, which are meta- 
plastically transformed vascular smooth muscle cells lo- 
cated in the media layer of afferent arterioles [2, 36]. The 
cellular mechanisms by which a drop of blood pressure 
enhances the secretion and an increase of pressure inhibits 
the secretion of renin are not well understood. Tobian 
[37] proposed the existence of a renal "baroreceptor" that 
responds to stretching of the afferent arteriole. This idea 
was further developed by Fray [8], who presented a math- 
ematical stretch receptor model based on his studies of 
the perfused rat kidney. According to this model it has 
been suggested that the intraluminal pressure in the affer- 
ent arterioles has influence on the stretch of the smooth 
muscle cells in the media layer. Tension of renal vascular 
smooth muscle cells leads to membrane depolarization 
[15] and in consequence to the activation of voltage- 
operated calcium channels (VOCC), which mediate trans- 
membrane calcium influx and an increase of the cytosolic 
concentration f calcium (cf. [18]). A rise of intracellular 
calcium is the key event for smooth muscle cell contrac- 
tion. It is likely, therefore, that this sequence of events 
provides the explanation for the myogenic autoregulation 
of renal flow [18]. Since JG cells are transformed vascular 
smooth muscle cells and since calcium is considered as 
an inhibitory signal for renin secretion (cf. [14]) it has 
been speculated that a similar mechanism involving the 
activation of VOCC also mediates the control of renin 
secretion by the pressure [9]. Experimental evidence for 
a functional role of VOCC in JG cells, however, is not 
unequivocal. On the one hand there are findings howing 
that the pressure ffect on renin secretion is attenuated 
by the calcium channel blocker verapamil ([9], cf. [14]). 
On the other hand there are also findings that verapamil 
can even inhibit renin secretion i dog kidneys [28]. More- 
over, evidence for a functional role of dihydropyridine- 
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sensitive calcium channels in the control o f ren in  secretion 
from isolated rat kidneys is controversial [6, 13, 16, 24]. 
In order to get basic informat ion about the cellular 
mechanisms underlying the renal baroreceptor con- 
troll ing renin release it appeared reasonable to examine 
thoroughly the functional role of VOCC in this process. 
For  control it also seemed meaningful  to moni tor  renal 
vascular esistance in parallel, because this parameter is
known to be strongly dependent on the activity of VOCC. 
We have recently shown that the isolated rat kidney is a 
suitable model for the study of renin secretion and renal 
vascular esistance in parallel [31]. With this model we 
have therefore examined the effects of organic calcium 
antagonists and agonists on the pressure dependence of
renin secretion and flow. 
We found that organic calcium channel blockers 
abolished the pressure-induced changes in renal vascular 
resistance. Neither calcium channel agonists nor antag- 
onists, however, had influence on pressure-dependent re- 
n in secretion. 
flow rate was obtained from the revolutions ofthe peristaltic pump, 
which was calibrated before and after each experiment. Renal flow 
rate and perfusion pressure were continuously monitored by a po- 
tentiometric recorder (Kipp & Zonen, Delft, Netherlands). Stock 
solutions of the drugs to be tested (see below) were dissolved in 
freshly prepared perfusate and infused into the arterial limb of the 
perfusion circuit directly before the kidneys (peristaltic pump 2132 
Microperpex, LKB, Bomma, Sweden) at 1% of the rate of perfusate 
flow. For determination f perfusate renin activity (pRA) aliquots 
(about 100 gl) were drawn from the arterial limb of the circulation 
and the renal venous effluent. The samples were centrifuged (4 ~ C) 
at 1500 g for 15 min (Sorvall RT 6000) and the supernatants were 
stored at -20~ until assayed for renin activity. 
Experimental protocol. After a 25-min equilibration period at con- 
stant perfusion pressure of 100 mm Hg, renal artery pressure was 
increased stepwise (20 mm Hg) to 120, 140, and 160 mm Hg (16, 
18.6 and 21.3 kPa). Each pressure level was maintained for 5 min 
and perfusate samples for determination f renin activity were taken 
after 1, 3 and 5 rain. From the maximum of 160 mm Hg, renal 
perfusion pressure was first returned to 100 mm Hg and, after a 5- 
min period, was lowered stepwise to 80, 60, and 40 mm Hg (10.6, 
8.0, 5.3 kPa) in the same way as it had previously been increased to 
160 mm Hg. Controls and the experiments with calcium antagonists 
were performed with the same kidney preparations. 
Materials and methods 
Male SIV strain rats (250-350 g body weight), having free access 
to commercial pellet chow and tap water, were obtained from the 
local animal house and used throughout. Kidney perfusion was 
performed in a recycling system according to the technique of 
Schurek and Alt [33] as described in detail previously [31]. In brief: 
the animals were anaesthetized with 150 mg kg -1 5-ethyl-(U- 
methytpropyl)-2-thiobarbituric acid (Inactin, Byk Gulden, Kon- 
stanz, FRG). Volume loss during the preparation was compensated 
by intermittent injections of physiological saline (about 2.5 ml 
totally) via a catheter that was inserted into the jugular vein. After 
opening of the abdominal cavity by a midline incision the right 
kidney was exposed and placed in a thermostatically controlled 
metal chamber. The right ureter was cannulated with a small 
polypropylene tube (PP-10), which was connected toa larger poly- 
ethylene catheter (PE-50). After intravenous heparin injection (2 U 
g-1, Liquemin, Roche, Basel, Switzerland) the aorta was clamped 
distal to the right renal artery and the large vessels branching off 
the abdominal orta were ligated. A double-barrelled cannula was 
inserted into the abdominal orta and placed close to the origin of 
the right renal artery. After ligation of the aorta proximal to the right 
renal artery the aortic lamp was quickly removed and perfusion was 
started in situ with an initial flow rate of 8 ml rain- 1. The right 
kidney was excised and perfusion at constant pressure (100 mm Hg, 
13.3 kPa) was established. To this end renal artery pressure was 
monitored through the inner part of the perfusion cannula (Statham 
transducer P 10 EZ) and the pressure signal was used for feedback 
control of a peristaltic pump. The perfusion circuit was closed by 
draining the renal venous effluent via a metal cannuta back into a 
reservoir (200-220 ml). The basic perfusion medium, which was 
taken from the thermostated (37 ~ C) reservoir, consisted of a modi- 
fied Krebs-Henseleit solution containing all physiological amino 
acids in concentrations between 0.2 mM and 2.0 mM plus 8.7 mM 
glucose, 0.3 mM pyruvate, 2.0mM L-lactate, 1.0mM 2-oxo- 
glutarate, 1.0 mM L-malate and 6.0 mM urea. The perfusate was 
supplemented with 6 g/100 ml bovine serum albumin, 0.1 g/100 ml 
inulin, and with freshly washed human red blood cells (10 + 2% 
haematocrit). Ampicillin (3 mg/100 ml) and flucloxacillin (3 mg/ 
100 ml) were added to inhibit possible bacterial contamination f 
the medium. To improve the functional preservation f the prep- 
aration, the perfusate was continuously dialysed against a 25-fold 
volume of the same composition but without erythrocytes and albu- 
min. For oxygenation of the perfusion medium the dialysate was 
gassed with a 95% oxygen, 5% carbon dioxide mixture. Perfusate 
Determination of renin activity. Perfusate samples were incubated 
for 1.5 h at 37~ with plasma of bilaterally nephrectomized male 
rats as renin substrate [27]. The angiotensin I generated was deter- 
mined by radioimmunoassay (Medipro AG, Teufen, Switzerland). 
Renin release. In a previous tudy performed with the same exper- 
imental model we have found that renin is not inactivated during 
its passage through isolated perfused rat kidneys [31]. Therefore, 
renin secretory rates could be calculated from the arteriovenous 
differences of perfusate renin activity and the corresponding renal 
flow rates. 
Determination of sodium and potassium. Sodium and potassium con- 
centrations were measured inperfusate and urine samples by means 
of a flame photometer quipped with an internal caesium standard 
(Instrumentation Laboratory 943). 
Calculation of glomerular filtration rate. The glomerular filtration 
rate was calculated from the inulin clearance. Following acid hy- 
drolysis of inulin, the fructose concentration was measured 
spectrophotometrically ccording to the method described by 
Schmidt [30]. 
Agents. Pyruvate and the kit for fructose determination were 
obtained from Boehringer, Mannheim, FRG. Ampicillin and 
flucloxacillin were from Beecham, Bern, Switzerland. Glutamate, 
urea, and 2-oxoglutarate were obtained from Merck, Darmstadt, 
FRG. L-Malic acid and L-lactate as sodium salts were provided by 
Serva, Heidelberg, FRG. L-Amino acids were from Braun/Mel- 
sungen, FRG (Aminoplasmal paediatric free of carbon hydrate). 
Inulin was provided by Laevosan, Linz, Austria. Nifedipine, 
verapamil, angiotensin II, isoproterenol, bumetanide and bovine 
serum albumin (fraction V powder) were purchased from Sigma 
International. Bay K 8644 and nitrendipine were provided by Bayer, 
Leverkusen, FRG. Stock solutions of the drugs to be tested were 
0.1 M in dimethylsulphoxide. The final dimethylsulphoxide concen- 
tration in the perfusion medium was less than 0.01%. 
Statistics. Levels of significance were calculated by using Student's 
t-test. P < 0.05 was considered significant. 
Results 
Kidneys were usually perfused in vitro for 2 h. In order 
to perceive a possible functional instabil ity of the prep- 
Table I. Parameters ofexcretory kidney function" 
Parameter 30 min 60 min 90 min 
Urine flow rate 
(glmin-lg-1) 43+ 5 58_+ 7 96 4-11 
GFR(plmin- lg -1) 958+12 961+_10 967-1-12 
TN~ (% of filtered load) 95 4- 2 92 _+ 3 87 _+ 2 
Isolated rat kidneys were perfused at renal artery pressure of 
100 mm Hg (13.3 kPa). Urine samples for determination of glom- 
erular filtration rate (GFR) and tubular sodium reabsorption (TN~) 
were collected at 30, 60 and 90 min after the onset of perfusion. 
Values are means _+ SEM of ten experiments 
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Fig. 1. Pressure/flow relationship (O) and pressure-dependent r in 
release (9 from isolated perfused rat kidneys run under control 
conditions (upper panel). Renin secretory rates (RSR) at distinct 
pressure levels were calculated from the arteriovenous difference of 
renin activity of perfusate and from the corresponding renal flow 
rates (ANG, angiotensin). Values are means _+ SEM from ten differ- 
ent experiments. Lower panels: effect of nifedipine (5pM), 
nitrendipine (3 I-tM) and verapamil (5 BM), three different organic 
calcium channel blockers, on renal autoregulation fflow and renin 
secretory rates. The drugs were continuously infused into the arterial 
limb of the circulation with a rate of 1% of renal perfusate flow. 
Values are means • SEM, n = 5. *, Significantly different from 
control (P < 0.05) 
arations we also determined excretory kidney function. 
To this end, urine samples were collected half-hourly and 
glomerular filtration rate and tubular sodium reabsorp- 
tion were determined. Values for urine flow rates, glom- 
erular filtration rates and sodium reabsorption are listed 
in Table 1. 
During control periods, when kidneys were perfused 
at a renal artery pressure of 100 mm Hg, flow rates were 
14.9 4- 0.4 ml rain -1 g-1 (mean • SEM; n = 10) (Fig. 1, 
upper panel). A stepwise increase of perfusion pressure 
to values of 120, 140 and 160 mm Hg caused slight but not 
significant (P > 0.05) increases of flow rates to 15.3 4- 0.6, 
15.8 4- 0.5 and 16.1 4- 0.7 ml rain - t  g-a respectively 
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Fig. 2. Effect of of increasing renal artery pressure from 100 to 
140 mm Hg and of angiotensin I I  (Ang H) (100 pM) on renal flow 
rate and renin release. Values are means 4- SEM, n = 5. *, Signifi- 
cantly different from control (P < 0.05) 
(Fig. 1). Reductions of renal artery pressure to 80, 60 and 
40 mm Hg, on the other hand, resulted in almost linear 
decreases of perfusate flow to 12.8 + 0.8, 9.4 + 0.5 and 
5.5 + 0.3 ml min-  t g-  t respectively (Fig. 1). 
Renin secretion rates at 100 mm Hg were 4.2 + 0.7 (ng 
angiotensin I h -1) min - t  g - t  (mean_+ SEM, n = 10) 
(Fig. 1, upper panel). A stepwise increase of perfusion 
pressure to 120, 140 and 160 mm Hg did not further 
significantly inhibit renin release (Fig. 1). Nonetheless, 
renin secretion was still inhibitable by angiotensin II 
(100pM) and could be stimulated by isoproterenol 
(10 nM) within this pressure range (Figs. 2 and 8). 
Stepwise reductions of renal artery pressure below 
100 mm Hg were paralleled by exponential increases of 
renin secretory rates. At pressure values of 80, 60 and 
40 mm Hg, renin secretion rates were 16 + 3, 63 + 8 and 
129 + 10 (ng angiotensin I h - t )  min - t  g-1 respectively 
(n = 10) (Fig. 1). Enhancement of renin secretion by a 
reduction of perfusion pressure was of rapid onset and 
was apparent within the first 2 rain after the drop of 
pressure (Fig. 3). 
The organic calcium channel blocker nifedipine 
(5 gM) caused significant increases of renal flow rates 
(P < 0.05) in the pressure range 100-160 mm Hg (n = 5) 
(Fig. 1). Perfusate flow rates in the presence of nifedipine 
(5 ~tM) were 17.1 4- 0.5, 19.2 4- 1.0, 22.0 4- 0.6 and 
22.9 ___ 0.5 ml rain - t g -  1 at pressures of 100, 120, 140 and 
160 mm Hg respectively. Flow rates at 80, 60 and 40 mm 
Hg were not significantly altered by nifedipine (Fig. 1). 
At the same time nifedipine did not significantly affect 
pressure-modulated renin secretion rates in the range 
40-160 mm Hg (Fig. 1). At concentrations higher than 
5 pM, nifedipine (25 gM, 50 pM) did not further decrease 
renal vascular esistance and also did not stimulate renin 
release (Fig. 4). In addition to the renal vascular elax- 
ation, nifedipine (5 gM) also increased urinary sodium 
excretion from 7.7 4- 0.5 pmol min-  ~ g -  ~ under control 
conditions to maximally 11.8 4- 0.9 gmol rain -~ g-~ at a 
perfusion pressure of 100 mm Hg. A rise of the sodium 
chloride load at the macula densa acts as an inhibitory 
158 
&OmmHg 
16 
~' i  12 
O r- 
,- ~ 10 
o~X 
q 140 
x 120 "1 
~" 100. 
x 80-  
"i 60-  r  
x 40.  
20.  c- ,< rt" 
5rain 
I I 
Fig. 3. Time courses of renal flow rate and renin secretion rate in 
response to decreasing perfusion pressure from 100 to 40 mm Hg 
(13.3 to 5.3 kPa). Values are means + SEM, n = 10. *, Significantly 
different from control 
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Fig. 4. Dose-dependent effects of the dihydropyridine calcium an- 
tagonist nifedipine on renal flow and renin secretory rates at pressure 
values of 100 mm Hg and 140 mm Hg (13.3 and 18,6 kPa). Values 
are means from three different experiments. *, Significantly differ- 
ent from control (P < 0.05) 
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Fig. 6. Dose/response curves of the organic alcium channel blocker 
verapamil. Perfusion pressure was held constant at 100 mm Hg. 
Values are means _+ SEM, n-= 5. *, Significantly different from 
control (P < 0.05) 
signal for renin secretion [35]. It appears, therefore, not 
unlikely that nifedipine stimulated renin release from re- 
nal JG cells directly via inhibition of VOCC and at the 
same time decreased renin secretion by activating the 
inhibitory macula densa mechanism. As a consequence, 
the net amount of renin released from JG cells would 
be unchanged. To test for the latter possibility we used 
bumetanide, an inhibitor of the macula densa Na+-K  +- 
2C1- cotransport [11]. As shown in Fig. 5, bumetanide 
(50 gM) increased the basal flow rate from 15.8 + 0.5 to 
17.0 _+ 0,5 ml min-~ g-1 and renin secretory rates from 
5.0 _+ 0.8 to 12 _ 1.2 (ng angiotensin I h - ] )  min -1 g-1. 
Those effects of bumetanide were paralleled by an in- 
crease of urinary sodium excretion from 6.5-t-0.5 to 
26.4 _+ 2.0 gmol min-  ~ g-  2. However, nifedipine (5 gM) 
even in the presence of 50 I~M bumetanide did not signifi- 
cantly affect renin secretion (Fig. 5). 
Like nifedipine, nitrendipine, another dihydropyridine 
derivative [1] used at a concentration of 3 gM, signifi- 
cantly increased renal flow rate at pressure values of 100, 
120, 140, and 160 mm Hg resulting in an almost linear 
pressure/flow curve (n = 5) (Fig. 1). Like nifedipine, 
nitrendipine did not significantly affect pressure-depen- 
dent renin release (Fig. 1). Verapamil at 5 gM [1] also 
abolished renal autoregulation of flow but had no effect 
on the relationship between renin secretion and perfusion 
pressure (Fig. 1). At higher concentrations verapamil led 
to a moderate and dose-dependent i crease of renin se- 
cretion at 100 mm Hg (Fig. 6). 
To evaluate further the potential role of VOCC in 
the control of renin secretion, we used Bay K 8644, a 
dihydropyridine calcium channel agonist [32] to enhance 
transmembrane calcium influx through voltage-operated 
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Fig. 7. Action of Bay K 8644 (5 p.M) on basal flow and renin se- 
cretory rates from isolated rat kidneys perfused at constant pressure 
of 100 mm Hg. The middle trace indicates the renin activities in 
the arterial (O) and the venous (11) perfusate. The long-lasting 
vasoconstricting effect of Bay K 8644 was completely reversed by 
verapamil (5 gM). Values are means 4- SEM, n = 5. -k, Significantly 
different from control (P < 0.05) 
1[:3) 
x 
x 
o _ 
,TE  
7- 
(33 
x 
7" 
18 
16 
14 
12 
10 
8 
I soprotereno l  
Bay K 8644 
159 
x 
x 
03 
c 
< 
< 
' oh  
x 30 = 
'c  25.  E 
x 20-  
"T'.-c 15-  
• 
10-  
or< 5-  
0 
5ram 
i i 
Fig. 8. Effect of Bay K 8644 (5 pM) on flow rates and renin secretion 
rates from isolated kidneys stimulated with isoproterenol (10 nM). 
In the middle trace are shown the renin activities in the arterial (O) 
and the venous (11) perfusate. Values are means _+ SEM, n = 5. -k, 
Significantly different from control (P < 0.05) 
calcium channels. As shown in Fig. 7 Bay K 8644 (5 gM) 
caused a prompt and long-lasting decrease of  renal f low 
rate from 14.8+_0.7 to 8 .2_+0.4ml  rain - t  g - t  when 
kidneys were perfused at 100 mm Hg, and this vaso- 
constriction was completely reversed by verapamil 
(5 pM). The vasoconstrictor action of  Bay K 8644 was 
paralleled by an increase of  the arteriovenous difference 
of  renin activity in the perfusate in such a way that Bay 
K 8644 did not significantly affect renin secretion (Fig. 7). 
Bay K 8644 (5 laM) also had no effect on renin secretion 
stimulated by isoproterenol (J0 nM) (Fig. 8). 
Discussion 
Pressure-dependent renin secretion from renal juxta- 
glomerular (JG) cells makes an important contribution 
to the homeostasis of  systemic blood pressure [12]. The 
cellular baroreceptor mechanism that leads to stimulation 
of renin secretion when renal artery pressure falls is still 
unknown. From the finding that pressure-controlled re- 
nin release is also preserved in non-filtering kidneys it 
was concluded that renal "baroreception" resides in the 
renal vasculature rather than being related to tubular, in 
particular to the macula densa, function (cf. [14]). 
In parallel to the inhibition of  renin secretion a rise of  
renal perfusion pressure also causes an increase of  renal 
vascular tone thus keeping blood f low through the kid- 
neys constant over a wide pressure range, a phenomenon 
referred to as the renal autoregulation of  f low [18]. 
Since JG ceils develop from vascular smooth muscle 
cells by reversible metaplastic transformation [2, 36], it 
is not unlikely that both renin secretion and myogenic 
control of  vascular tone could primarily be controlled by 
a similar cellular signal transduction mechanism (cf. [14]). 
In fact, a number of  vasoconstrictor agents such as 
angiotensin II have been found to inhibit renin release 
from JG cells, whereas renal vasodilators such as 
isoproterenol stimulate renin secretion [13, 14] suggesting 
that the amount of renin released from JG cells is in- 
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versely related to the state of tension of renal vascular 
smooth muscle cells. 
The cellular mechanisms underlying myogenic ontrol 
of vascular tone are not yet completely understood. Renal 
autoregulation of flow in vivo and in vitro, however, was 
blunted by organic calcium channel blockers [4, 23, 25] 
suggesting that voltage-operated calcium channels 
(VOCC) are somehow involved in the pressure control of 
vascular esistance. On the other hand, an increase of the 
intracellular calcium concentration is believed to act as 
an inhibitory signal for renin secretion from JG cells [13, 
14] and it is still an open question whether transmem- 
brane calcium influx through VOCC contributes to this 
phenomenon. 
In our study we have therefore tested for a functional 
role of VOCC in the pressure control of renin secretion. 
To this end we have used the model of isolated perfused 
rat kidneys because this preparation allows pharmaco- 
logical effects on renal function to be monitored under 
controlled in vitro conditions. Since functional deterio- 
ration of cell-free perfused isolated kidney preparations 
has been reported to be at least in part prevented by 
increasing the oxygen supply to the kidneys [22], a 10% 
fraction of human red cells was added to the perfusate. 
In previous studies pressure-dependent renin secretion 
and autoregulation of flow have been found to be rather 
well preserved under these conditions [38]. In addition, 
the perfusion medium was regenerated by continuous 
dialysis during the experiments and the comparably low 
urine flow rates and the relatively high reabsorption rate 
for sodium argue in favour for the functional conser- 
vation of the isolated kidneys. Our finding that decreasing 
perfusion pressure in the range 80-40 mm Hg resulted 
in a linear pressure/flow relationship (Fig. 1) suggests 
that the renal vasculature was maximally dilated and 
myogenic regulation of vascular tone was absent in this 
pressure range. At the same time, pressure-dependent 
renin secretion was well preserved corresponding to an 
increase of secretion rate of approximately 2.8 (ng 
angiotensin I h- l )  min-1 g-1 mm Hg -1 when renal 
artery pressures were lowered to values below 80 mm Hg 
(Fig. 1). This suggests that renin release was not related 
to renal vascular tone within this range of perfusion pres- 
sure, a finding that is compatible with results obtained 
with conscious rats [5] but at variance with findings 
obtained in dogs [7, 20]. In the dogs, pressure-dependent 
renin secretion was found mainly to occur within the 
autoregulatory range [7, 20] and it did not increase further 
when the renal artery pressure was reduced below 60 mm 
Hg [7, 20]. The reason for those differences between the 
pressure dependence of renin release in vitro and in the 
intact animal is not known. However, pressure modu- 
lation of renin secretion appears to require a basal flow to 
become ffective. Thus, pressure-dependent renin release 
from rabbit afferent arterioles has only been found with 
a free-flow system allowing parallel changes of the 
perfusate flow [3], whereas pressure dependence was not 
preserved by using a similar stop-flow technique [29]. 
Since, in contrast o the in vivo situation, isolated per- 
fused kidney preparations are characterized by a rela- 
tively high basal flow rate in the lower pressure range 
also, this could be a reason why we found pressure depen- 
dence to be preserved also at values lower than 60 mm 
Hg. 
Elevating the perfusion pressure above 100 mm Hg 
only led to a slight increase of perfusate flow indicating 
that myogenic ontrol of flow was preserved (Fig. 1). 
Within this autoregulatory ange the pressure/renin se- 
cretion relationship was characterized by a plateau level 
with increasing perfusion pressure causing no further sig- 
nificant inhibition of renin release (Fig. 1). Within the 
plateau phase renin secretion was still regulatible, as indi- 
cated by the inhibitory effect of angiotensin II and by 
the stimulatory effect of isoproterenol (Figs. 3 and 8). A 
similar relationship between renin secretion and renal 
artery pressure with a slope, threshold pressure and a 
plateau phase has also been obtained in conscious dogs 
[7, 20] and rats [5, 171. 
Our finding that autoregulation of renal flow was 
blunted by different organic calcium entry blockers 
(Fig. 1) is in good accordance with previous studies 
suggesting that influx of calcium into renal vascular 
smooth muscle cells through VOCC plays an essential 
role in the myogenic response to increasing renal artery 
pressure [4, 23, 25]. The prompt and long-lasting vasocon- 
strictor effect of Bay K 8644, a dihydropyridine calcium 
channel agonist [32], which is thought o enhance trans- 
membrane calcium influx [19, 32], is also compatible with 
this concept (Fig. 7). 
More unexpected was that three structurally different 
calcium antagonists did not alter renin secretion in the 
pressure range 40-160 mm Hg, which led to a disso- 
ciation of renin release from the myogenic ontrol of flow 
(Fig. 1). Bay K 8644 also did not alter renin release from 
the isolated kidneys, not even if it had first been stimu- 
lated with isoproterenol (Fig. 8). 
Under the assumption that VOCC in vascular smooth 
muscle cells and in renal juxtaglomerular cells should 
have similar pharmacological properties, the sum of our 
results suggests that VOCC are not essentially involved 
in the baroreceptor mechanism controlling renin se- 
cretion in the isolated rat kidney. 
At a first view our findings and conclusions eem to 
be at odds with several reports suggesting an essential 
role of VOCC in the control of renin secretion from renal 
juxtaglomerular cells [9]. It must be noted, however, that 
the experimental evidence available on this question is 
already contradictory. For instance Hackenthal and 
Taugner [13] observed that 1 laM Bay K 8644 caused a 
50% reduction of basal renin release and a 10% increase 
in vascular esistance in the isolated perfused rat kidney, 
while Dietz [6] found a 60% increase in vascular resistance 
and no change of renin secretion under the same con- 
ditions. The latter author also observed no effect of Bay 
K 8644 on renin secretion stimulated by hypotension. 
With results very similar to our own (Figs. 4, 6), he also 
found that verapamil but not nifedipine at higher concen- 
trations increased renin secretion at high pressures [6]. 
Roy et al. [28] reported that intrarenal infusion of 
verapamil n anaesthetized dogs caused an inhibition of 
renin secretion. Only in postischaemic papaverine-treated 
kidneys did they find a stimulation of renin secretion by 
161 
verapami l  [28]. St imulatory  effects of  verapami l  on renin 
secretion are usual ly seen at concentrat ions higher than 
10 gM (cf. [14]), a f inding that was also obta ined in this 
study (Fig. 6). Inhibi t ion of  VOCC by verapamil ,  how- 
ever, occurs in the low micromolar  concentrat ion range 
as also seen in this study (Fig. 1). Recently it was shown 
that verapami l  in the micromolar  concentrat ion range is 
capable also of  b locking potass ium channels in vascular 
smooth muscle cells [26]. Since potass ium channels are 
predolrf inant in JG  cells [21] it can not  be ruled out that 
st imulat ion of  renin secretion by verapami l  is due to 
interference with non-calc ium channels. 
A l though nifedipine and related drugs signif icantly 
increased ur inary sodium excretion, the possibi l i ty ap- 
pears less l ikely that inhibit ion of  renin release via the 
macula densa mechanism neutral ized a direct st imulatory 
effect on JG  cells by blocking calcium influx through 
VOCC. Thus, 50 gM bumetanide,  an inhibi tor  of  the 
Na+-K+-2C1 - cot ranspor t  [11], reduced renal vascular 
resistance and at the same time signif icantly increased 
ur inary sodium excret ion and renin release, suggesting 
that the macula  densa t ransport  function was effectively 
inhibited. However,  even under those condit ions 
nifedipine did not  signif icantly affect, and in part icular  
did not st imulate, renin secretion from isolated perfused 
kidneys (Fig. 5). 
Taken together our  f indings indicate and thus conf i rm 
previous results that  VOCC are essential mediators  of  the 
renal vascular myogenic response to pressure but  they 
also suggest hat VOCC are not  essential ly involved in 
the baroreceptor  mechanism control l ing renin secretion. 
Thus, the elucidat ion of  this mechanism requires future 
work and we think that the isolated perfused rat k idney 
is a suitable model  for the further invest igat ion of  this 
question. Our  f indings show that the cellular mechanisms 
mediat ing the contro l  of  renin secretion by pressure are 
fast-operat ing (Fig. 2). This character ist ic may be helpful 
to nar row-down possible candidates for baroreceptor  sig- 
nals. 
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